Interpretation of the evidence for the efficacy and safety of statin therapy by Collins, Rory, Prof, Reith, Christina, FRCP (Glasg.), Emberson, Jonathan, PhD, Armitage, Jane, Prof, Baigent, Colin, Prof, Blackwell, Lisa, BSc, Blumenthal, Roger, Prof, Danesh, John, Prof, Smith, George Davey, Prof, DeMets, David, Prof, Evans, Stephen, Prof, Law, Malcolm, Prof, MacMahon, Stephen, Prof, Martin, Seth, MD, Neal, Bruce, Prof, Poulter, Neil, Prof, Preiss, David, PhD, Ridker, Paul, Prof, Roberts, Ian, Prof, Rodgers, Anthony, Prof, Sandercock, Peter, Prof, Schulz, Kenneth, Prof, Sever, Peter, Prof, Simes, John, Prof, Smeeth, Liam, Prof, Wald, Nicholas, Prof, Yusuf, Salim, Prof, Peto, Richard, Prof

Get full text

Challenges of Non–Intention-to-Treat Analyses by DeMets, David L, Cook, Thomas

Get full text

The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics by McMurray, John J.V., DeMets, David L., Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Langkilde, Anna Maria, Martinez, Felipe A., Bengtsson, Olof, Ponikowski, Piotr, Sabatine, Marc S., Sjöstrand, Mikaela, Solomon, Scott D.

Get full text

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy by Docherty, Kieran F, Jhund, Pardeep S, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Martinez, Felipe A, Ponikowski, Piotr, DeMets, David L, Sabatine, Marc S, Bengtsson, Olof, Sjöstrand, Mikaela, Langkilde, Anna Maria, Desai, Akshay S, Diez, Mirta, Howlett, Jonathan G, Katova, Tzvetana, Ljungman, Charlotta E A, O’Meara, Eileen, Petrie, Mark C, Schou, Morten, Verma, Subodh, Vinh, Pham Nguyen, Solomon, Scott D, McMurray, John J V

Get full text

Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF Trial by Kosiborod, Mikhail N., Jhund, Pardeep S., Docherty, Kieran F., Diez, Mirta, Petrie, Mark C., Verma, Subodh, Nicolau, Jose C., Merkely, Béla, Kitakaze, Masafumi, DeMets, David L., Inzucchi, Silvio E., Køber, Lars, Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Solomon, Scott D., Bengtsson, Olof, Lindholm, Daniel, Niklasson, Anna, Sjöstrand, Mikaela, Langkilde, Anna Maria, McMurray, John J.V.

Get full text

When Can Intermediate Outcomes Be Used as Surrogate Outcomes? by DeMets, David L, Psaty, Bruce M, Fleming, Thomas R

Get full text

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF) by Serenelli, Matteo, Böhm, Michael, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Martinez, Felipe A, Ponikowski, Piotr, Sabatine, Marc S, Solomon, Scott D, DeMets, David L, Bengtsson, Olof, Sjöstrand, Mikaela, Langkilde, Anna Maria, Anand, Inder S, Chiang, Chern-En, Chopra, Vijay K, de Boer, Rudolf A, Diez, Mirta, Dukát, Andrej, Ge, Junbo, Howlett, Jonathan G, Katova, Tzvetana, Kitakaze, Masafumi, Ljungman, Charlotta E A, Verma, Subodh, Docherty, Kieran F, Jhund, Pardeep S, McMurray, John J V

Get full text

Data monitoring committee interim reports: We must get there soon by DeMets, David L, Wittes, Janet

Get full text

Genomic surveillance to combat COVID-19: challenges and opportunities by Robishaw, Janet D, Alter, Scott M, Solano, Joshua J, Shih, Richard D, DeMets, David L, Maki, Dennis G, Hennekens, Charles H

Get full text

Achieving effective informed oversight by DMCs in COVID clinical trials by DeMets, David L., Fleming, Thomas R.

Get full text

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF by Martinez, Felipe A., Serenelli, Matteo, Nicolau, Jose C., Petrie, Mark C., Chiang, Chern-En, Tereshchenko, Sergey, Solomon, Scott D., Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Ponikowski, Piotr, Sabatine, Marc S., DeMets, David L., Dutkiewicz-Piasecka, Monika, Bengtsson, Olof, Sjöstrand, Mikaela, Langkilde, Anna Maria, Jhund, Pardeep S., McMurray, John J.V.

Get full text

Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF by Jackson, Alice M., Dewan, Pooja, Anand, Inder S., Bělohlávek, Jan, Bengtsson, Olof, de Boer, Rudolf A., Böhm, Michael, Boulton, David W., Chopra, Vijay K., DeMets, David L., Docherty, Kieran F., Dukát, Andrej, Greasley, Peter J., Howlett, Jonathan G., Inzucchi, Silvio E., Katova, Tzvetana, Køber, Lars, Kosiborod, Mikhail N., Langkilde, Anna Maria, Lindholm, Daniel, Ljungman, Charlotta E.A., Martinez, Felipe A., O’Meara, Eileen, Sabatine, Marc S., Sjöstrand, Mikaela, Solomon, Scott D., Tereshchenko, Sergey, Verma, Subodh, Jhund, Pardeep S., McMurray, John J.V.

Get full text

Society for Clinical Trials Data Monitoring Committee initiative website: Closing the gap by DeMets, David L, Halabi, Susan, Thabane, Lehana, Wittes, Janet

Get full text

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials by Hicks, Karen A., Mahaffey, Kenneth W., Mehran, Roxana, Nissen, Steven E., Wiviott, Stephen D., Dunn, Billy, Solomon, Scott D., Marler, John R., Teerlink, John R., Farb, Andrew, Morrow, David A., Targum, Shari L., Sila, Cathy A., Thanh Hai, Mary T., Jaff, Michael R., Joffe, Hylton V., Cutlip, Donald E., Desai, Akshay S., Lewis, Eldrin F., Gibson, C. Michael, Landray, Martin J., Lincoff, A. Michael, White, Christopher J., Brooks, Steven S., Rosenfield, Kenneth, Domanski, Michael J., Lansky, Alexandra J., McMurray, John J.V., Tcheng, James E., Steinhubl, Steven R., Burton, Paul, Mauri, Laura, O’Connor, Christopher M., Pfeffer, Marc A., Hung, H.M. James, Stockbridge, Norman L., Chaitman, Bernard R., Temple, Robert J., Fitter, Heather D., Illoh, Kachikwu, Cavanaugh, Kenneth J., Scirica, Benjamin M., Irony, Ilan, Brown Kichline, Rachel E., Levine, Jonathan G., Park, Anna, Sacks, Leonard, Szarfman, Ana, Unger, Ellis F., Wachter, Lori Ann, Zuckerman, Bram, Mitchel, Yale, Peddicord, Douglas, Shook, Thomas, Kisler, Bron, Jaffe, Charles, Bartley, Rhonda, DeMets, David L., Mencini, MariJo, Janning, Cheri, Bai, Steve, Lawrence, John, D’Agostino, Ralph B., Pocock, Stuart J.

Get full text

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular... by McMurray, John J.V., DeMets, David L., Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Langkilde, Anna M., Martinez, Felipe A., Bengtsson, Olof, Ponikowski, Piotr, Sabatine, Marc S., Sjöstrand, Mikaela, Solomon, Scott D., McMurray, John JV, DeMets, David L, Inzucchi, Silvio E, Køber, Lars, Kosiborod, Mikhail N, Langkilde, Anna Maria, Martinez, Felipe A, Ponikowski, Piotr, Sabatine, Marc S, Sjöstrand, Mikaela, Solomon, Scott D, Diez, Mirta, Nicolau, Jose, Katova, Tzvetana, O'Meara, Eileen, Howlett, Jonathan, Verma, Subodh, Ge, Junbo, Belohlavek, Jan, Schou, Morten, Böhm, Michael, Merkely, Bela, Chopra, Vijay, Kitakaze, Masafumi, de Boer, Rudolf A., Drozdz, Jaroslaw, Tereshchenko, Sergey, Dukat, Andrej, Ljungman, Charlotta, Chiang, Chern‐En, Petrie, Mark, Desai, Akshay, Anand, Inder, Pham, Vinh Nguyen, Pfeffer, Marc A., Pocock, Stuart, Swedberg, Karl, Rouleau, Jean L., Chaturvedi, Nishi, Ivanovich, Peter, Levey, Andrew S., Christ‐Schmidt, Heidi, Held, Claes, Varenhorst, Christoph, Christersson, Christina, Mann, Johannes, Holmgren, Pernilla, Hallberg, Theresa, Langkilde, AnnaMaria, Sjöstrand, Mikaela, Denison, Hans, Reicher, Barry, Bengtsson, Olof, Fox, Ywonne, Forsby, Mikael, Alenhag, Eva‐Lena, Nilsson, Ann, Kazanowska, Kinga, Olofsson, Eva Lavik, Karup, Cathrine, Ekedahl‐Berggren, Maria, Klockargård, Anna‐Lena, Kempe, Karin, Selvén, Mathilda

Get full text

Cardiovascular Drug Development by Fordyce, Christopher B., MD, MSc, Roe, Matthew T., MD, MHS, Ahmad, Tariq, MD, MPH, Libby, Peter, MD, Borer, Jeffrey S., MD, Hiatt, William R., MD, Bristow, Michael R., MD, PhD, Packer, Milton, MD, Wasserman, Scott M., MD, Braunstein, Ned, MD, Pitt, Bertram, MD, DeMets, David L., PhD, Cooper-Arnold, Katharine, MPH, Armstrong, Paul W., MD, Berkowitz, Scott D., MD, Scott, Rob, MD, Prats, Jayne, PhD, Galis, Zorina S., PhD, Stockbridge, Norman, MD, PhD, Peterson, Eric D., MD, MPH, Califf, Robert M., MD

Get full text

Alternatives to Intention-to-Treat Analyses—Reply by DeMets, David L, Cook, Thomas D

Get full text

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial by Baron, John A, Prof, Sandler, Robert S, Prof, Bresalier, Robert S, Prof, Lanas, Angel, Prof, Morton, Dion G, Prof, Riddell, Robert, Prof, Iverson, Erik R, MS, DeMets, David L, Prof

Get full text

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF by Docherty, Kieran F., Jhund, Pardeep S., Anand, Inder, Bengtsson, Olof, Böhm, Michael, de Boer, Rudolf A., DeMets, David L., Desai, Akshay S., Drozdz, Jaroslaw, Howlett, Jonathan, Inzucchi, Silvio E., Johanson, Per, Katova, Tzvetana, Køber, Lars, Kosiborod, Mikhail N., Langkilde, Anna Maria, Lindholm, Daniel, Martinez, Felipe A., Merkely, Béla, Nicolau, Jose C., O’Meara, Eileen, Ponikowski, Piotr, Sabatine, Marc S., Sjöstrand, Mikaela, Solomon, Scott D., Tereshchenko, Sergey, Verma, Subodh, McMurray, John J.V.

Get full text

Cardiovascular drug development: is it dead or just hibernating? by Fordyce, Christopher B, Roe, Matthew T, Ahmad, Tariq, Libby, Peter, Borer, Jeffrey S, Hiatt, William R, Bristow, Michael R, Packer, Milton, Wasserman, Scott M, Braunstein, Ned, Pitt, Bertram, DeMets, David L, Cooper-Arnold, Katharine, Armstrong, Paul W, Berkowitz, Scott D, Scott, Rob, Prats, Jayne, Galis, Zorina S, Stockbridge, Norman, Peterson, Eric D, Califf, Robert M

Get full text